APOA1 and atherosclerosis: Increased sPLA2 expression in mice led to decreased HDL and apoA-I levels, changes in HDL content (depleted phospholipids and CEs, increased proteins and TAGs), and accelerated HDL catabolism [310,311], and in humans and animal models correlates with atherosclerosis development [312,313,314].